Article summary
This preclinical mouse study found that psilocybin given before platinum- or taxane-based chemotherapy prevented peripheral neuropathy while preserving antitumour effects. The authors linked this protection to maintained mitochondrial transport within nerve fibres and associated changes in central nervous-system function.
Continue to the original publication for the complete article.